TrialJournal of ovarian research2025
Comparative study of cabergoline and hydroxychloroquine to prevent ovarian hyperstimulation syndrome (OHSS) in PCOS patients: a pilot randomized clinical trial.
Elnaz Salari et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.